Vivek Mani has over a decade of experience leading teams and consulting to clients on regulatory and litigation issues involving competition. His expertise includes collective actions, cartels, and mergers in Europe and the United States. Mr. Mani’s competition experience covers a range of industries, including automobiles, financial institutions, pharmaceuticals, retail, and telecommunications. Who’s Who Legal has recognized him as a Future Leader in the competition field.
Competition in financial markets
Mr. Mani consults to clients on class certification/collective action issues in antitrust matters in U.S. and UK financial markets. He has analyzed price fixing allegations related to asset and benchmark prices, as well as bid-ask spreads for financial instruments across various trading platforms. Mr. Mani has conducted empirical analyses of large proprietary datasets in the context of price fixing allegations.
Mr. Mani has consulted to pharmaceutical clients on numerous matters, including breach of contract, antitrust, product misrepresentation, and securities and intellectual property. He has addressed issues related to drug development, drug pricing and reimbursement, brand-to-brand competition, generic competition, and damages.
Mr. Mani has testified at an arbitration hearing on damages issues in a life sciences matter.
Mr. Mani leads merger review teams for the merging parties in the U.S. and Europe. He has assessed horizontal and vertical issues arising in a range of industries, including industrial goods, retail, technology, and telecommunications. Mr. Mani also has experience in sampling and survey design, and in conducting and critiquing surveys as part of Phase II merger inquiries in Europe.
On both sides of the Atlantic, Mr. Mani publishes and speaks extensively on topics related to class certification and collective actions, economic issues in the pharmaceutical industry, and merger analyses.
Mr. Mani is a member of Cornerstone Research’s Diversity, Equity, and Inclusion Council.
Intersection of Intellectual Property and Competition Policy in Recent Cases
EssilorLuxottica’s Acquisition of GrandVision
Cornerstone Research Named in 2022 Matters of the Year in U.S. and Europe
Economic Issues in Assessing Potential and Nascent Competition
Cornerstone Research Promotes Seven to Vice President
Estimating Harm in Invasion of Privacy and Data Breach Disputes
2021 Who’s Who Legal: Consulting Experts
- EssilorLuxottica’s Acquisition of GrandVision
- Meta/Kustomer Merger
- ICC Arbitration Involving Commercially Reasonable Efforts to Develop and Commercialize a Drug
- EC’s Phase II Investigation of Essilor/Luxottica Merger
- Selecta’s Acquisition of Pelican Rouge
- Alleged Theft of Trade Secrets for a Drug in Development